EyePoint Pharmaceuticals
EYPT
#5989
Rank
NZ$1.85 B
Marketcap
NZ$22.09
Share price
1.17%
Change (1 day)
122.16%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -NZ$0.4 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are NZ$31.37 Million. a decrease over its 2024 earnings that were of -NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.4 Billion63.24%
2024 -NZ$0.25 Billion104.29%
2023 -NZ$0.12 Billion-29.88%
2022 -NZ$0.17 Billion87.2%
2021 -NZ$90.4 Million38.58%
2020 -NZ$65.24 Million-24.56%
2019 -NZ$86.47 Million
2017 -NZ$39.44 Million22.59%
2016 -NZ$32.17 Million-8.02%
2015 -NZ$34.98 Million-296.09%
2014 NZ$17.83 M-174.02%
2013 -NZ$24.1 Million37.42%
2012 -NZ$17.54 Million-56.29%
2011 -NZ$40.12 Million-1062.38%
2010 NZ$4.16 M-250.43%
2009 -NZ$2.78 Million-89.5%
2008 -NZ$26.4 Million
2005 -NZ$16.28 Million56.99%
2004 -NZ$10.37 Million73.7%
2003 -NZ$5.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.7 Million-99.07% Bahamas
NRC Health
NRC
NZ$47.1 M-111.90%๐Ÿ‡บ๐Ÿ‡ธ USA